PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32457396-7	2020	Mechanistically, the Msi1-mTOR pathway drives keratinocyte-Paget-like cell conversion, and suppression of mTOR signaling with Rapamycin significantly rescued the Paget-like phenotype in Msi1-overexpressing transgenic mice.	Sirolimus	126-135	mechanistic target of rapamycin kinase	Mus musculus	106-110	
32457396-7	2020	Mechanistically, the Msi1-mTOR pathway drives keratinocyte-Paget-like cell conversion, and suppression of mTOR signaling with Rapamycin significantly rescued the Paget-like phenotype in Msi1-overexpressing transgenic mice.	Sirolimus	126-135	musashi RNA-binding protein 1	Mus musculus	186-190	
32457396-8	2020	Topical Rapamycin treatment improved extramammary PD-associated symptoms in humans, suggesting mTOR inhibition as a novel therapeutic treatment in PD.	Sirolimus	8-17	mechanistic target of rapamycin kinase	Homo sapiens	95-99